Bidhan A Shinkre

Title: Bidhan A Shinkre: Innovator in Hydrazone Compounds

Introduction

Bidhan A Shinkre is a notable inventor based in Ponda, India. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on hydrazone and diacyl hydrazine compounds. His research focuses on developing compounds that can inhibit critical pathways involved in protein degradation.

Latest Patents

Shinkre holds a patent for "Hydrazone and diacyl hydrazine compounds and methods of use." This patent discloses novel hydrazone and diacyl hydrazine derivatives that act as inhibitors of the endoplasmic reticulum-associated protein degradation (ERAD) pathway. Additionally, these compounds serve as potent and selective inhibitors of the p97 ATPase. The agents developed by Shinkre provide valuable tools for studying protein degradation and related processes involving p97. His work also includes methods for treating diseases or disorders where p97 inhibition and/or ER stress induction is an effective treatment.

Career Highlights

Bidhan A Shinkre is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to contribute to groundbreaking research in the field of health and medicine.

Collaborations

Shinkre has collaborated with esteemed colleagues such as Adrian U Wiestner and Yihong Ye. These collaborations enhance the impact of his research and contribute to advancements in the understanding of protein degradation mechanisms.

Conclusion

Bidhan A Shinkre's innovative work in hydrazone compounds exemplifies the importance of research in developing therapeutic agents. His contributions to the field of medicinal chemistry are significant and continue to influence the study of protein degradation and related diseases.